Cite Filings / MGX
Feed Companies Filings Check
Sign in

CIK 0001785279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
813909017
Phone
(510) 871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Filings Insiders Search text
All 156 Financials 36 Shareholder Meetings 2 Executive Compensation 29 Insider Trading 73 Beneficial Ownership Interest 5 Business Combinations 24 Public Offerings 18 Mutual Funds and ETFs 2 Others 24
›
Filed in
  1. No filings match these filters. Clear filters
  2. 8-K Event Other events 2024-12-10
  3. 8-K Event ● Results of operations 2024-11-13
  4. 8-K Event Other events 2024-09-03
  5. 8-K Event ● Results of operations 2024-08-14
  6. 8-K Event ● Results of operations · Regulation FD disclosure 2024-05-14
  7. 8-K Event ● Agreement ended · Results of operations · Regulation FD disclosure 2024-05-01
  8. 8-K Event ● Results of operations 2024-03-27
  9. 10-K Report Annual Report 2024-03-27
  10. 8-K Event Bylaws or fiscal year change 2024-02-13

Page 2 of 2 · 29 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…